Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

In vivo proton magnetic resonance spectroscopy (MRS) may be used to quantify brainstem neuronal degeneration in ALS because of the neuronal localization of N-acetylaspartate and N-acetylaspartylglutamate, together termed NA, which are estimated with this technique. We measured the ratio of NA to creatine/phosphocreatine(NA/Cr) with proton MRS at 3.0 tesla (T) in a 4.3-cm3 volume in the pons and upper medulla of 12 ALS patients and 17 age-matched control subjects. Brainstem NA/Cr was reduced in ALS versus control subjects (mean± SD: 1.57 ± 0.20 versus 1.95 ± 0.14; p< 0.0001). Patients with severe spasticity or prominent bulbar weakness had the lowest NA/Cr ratios; those with predominantly lower motor neuron limb weakness had near-normal ratios. We conclude that proton MRS may quantify region-specific neuronal dysfunction in ALS.

[1]  S. Topp,et al.  Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy , 1997, Neurology.

[2]  A. Thompson,et al.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.

[3]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[4]  Andrew P Jones,et al.  Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis) , 1995, Journal of the Neurological Sciences.

[5]  John R. Hodges,et al.  Progressive prosopagnosia associated with selective right temporal lobe atrophy. A new syndrome? , 1995, Brain : a journal of neurology.

[6]  D. Arnold,et al.  Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo , 1994, Neurology.

[7]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[8]  A. Plaitakis,et al.  Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartylglutamate in amyotrophic lateral sclerosis , 1993, Brain Research Bulletin.

[9]  J. Neale,et al.  Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[12]  L. Wilkins.  Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[13]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[14]  M. Fisher,et al.  Regional distribution of thrombomodulin in human brain , 1991, Brain Research.

[15]  Jeffrey D. Rothstein,et al.  Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS , 1991, Brain Research.

[16]  P M Matthews,et al.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.

[17]  J. Kurtzke,et al.  On the production of neurologists in the United States , 1991, Neurology.

[18]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[19]  P. Andres,et al.  The natural history of motoneuron loss in amyotrophic lateral sclerosis , 1988, Neurology.

[20]  J. Abbs,et al.  Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis , 1988, Neurology.

[21]  J. Hughes.  Pathology of amyotrophic lateral sclerosis. , 1982, Advances in neurology.

[22]  A. Brancati,et al.  DISTRIBUTION OF N‐ACETYL‐ASPARTIC AND N‐ACETYL‐ASPARTYL‐GLUTAMIC ACIDS IN NERVOUS TISSUE * , 1965, Journal of neurochemistry.

[23]  H. Tallan.  Studies on the distribution of N-acetyl-L-aspartic acid in brain. , 1957, The Journal of biological chemistry.

[24]  T. Lawyer,et al.  AMYOTROPHIC LATERAL SCLEROSIS: A Clinicoanatomic Study of Fifty-Three Cases , 1953 .